About James Gilmore

With a background in Molecular Biology, I have worked in the biotech industry in a variety of roles from Founding Scientist in a successful start-up, to a Marketing Exec covering over $1.6B in revenue. BrainSpores provides me with the opportunity to use my marketing and business strategy skills to help fellow researchers to be successful.

Three Reasons Why Biotech Turnarounds are so Hard

It’s difficult to imagine anyone launching a biotech company in anticipation of it stalling and becoming a turnaround three or five years later. Still, many companies find themselves just a few years after launch in a position where growth (if there was any) has stagnated and raising capital is increasingly difficult. In our experience there are three reasons why biotech turnarounds are so hard.

Are you hoarding marketing tactics? It’s time to declutter!

Marketing clutter accumulates the same as the detritus in a teenager’s room. Worn tactics are tossed about the floor, taking up valuable space. The laundry basket is overflowing with campaigns that have outlived their usefulness but nobody really wants to take the initiative to clean them up. Out dated materials for sales reps are littered about, like old homework assignments. It's time to declutter!

Negotiate or Haggle? How Would You Buy a PCR Machine?

Are you a haggler or a negotiator? I was talking with a research colleague, and she was certain that she was a negotiator- but the more we discussed her actions and intents as she tried to purchase a PCR machine, the less certain we both became. While we may want to think we are good negotiators the truth is that we might actually be hagglers. To find out if you are a haggler or negotiator, answer two quick questions.

Go to Top